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Abstract
Introduction Embryonal tumor with abundant neuropil and
true rosettes (ETANTR) is a rare subtype of primitive neuro-
ectodermal tumors first reported in 2000. It is rare among
the group of embryonal central nervous system tumors with
approximately 50 reported cases. ETANTR has been sug-
gested to be a separate entity among this group of tumors.
Case report Herein, we present only the second autopsy
case of ETANTR, which occurred in a 17-month-old boy,
and was located in the brainstem. The tumor was inoperable,
and despite chemotherapy, the child died 3 months after
initial hospitalization. A brain only autopsy was performed.
Discussion Neuropathological and neuroimaging examina-
tions suggest ETANTR grew by expansion rather than in-
vasion distorting anatomical structures of the posterior
fossa. We suggest that the characteristic histopathological
picture of the tumor is the result of multifocal and dispersed
germinative activity surrounded by mature neuropil-like
areas.
Conclusion ETANTR is a pediatric tumor occurring in chil-
dren under 4 with a significantly poor prognosis with more
cases and research required to characterize this rare embry-
onal tumor.
Keywords ETANTR . Embryonal tumor with abundant
neuropil and true rosettes . Pediatric brain tumor .
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Introduction
Embryonal neoplasms of the central nervous system (CNS)
are among the most aggressive of brain tumors in children.
Embryonal tumor with abundant neuropil and true rosettes
(ETANTR) is a histologically distinct embryonal tumor not
yet classified as a separate entity in the 2007 World Health
Organization (WHO) classification of central nervous system
tumors. According to this classification, embryonal tumors are
divided into three categories: medulloblastoma, atypical ter-
atoid/rhabdoid tumor (AT/RT), and CNS primitive neuroecto-
dermal tumors (PNET) [12, 17]. PNET is further divided into
five subtypes: CNS PNET, CNS neuroblastoma, CNS gan-
glioneuroblastoma, medullloepithelioma, and ependymoblas-
toma [12, 17]. ETANTR was first described by Eberhart et al.
in 2000 as a variant of pediatric embryonal brain tumors [5].
ETANTR is characterized by undifferentiated neuroepithelial
cells resembling those of classic PNET, abundant well-
differentiated neuropil, and ependymoblastic rosettes scat-
tered throughout the paucicellular regions of neoplastic neuro-
pil [7]. ETANTR is a unique subtype of CNS PNET and we
would support its distinction as a separate entity within CNS
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PNET in future WHO classifications of embryonal CNS
tumors. The number of reported cases of ETANTR remains
to be low. Approximately 50 cases and less than 20 papers of
ETANTR have been published. The largest single study of
ETANTR was published by Gessi who reviewed 29 cases
with seven original cases [7].
Herein, we present a case of ETANTR in a boy treated at
the Children’s University Hospital in Cracow, Poland as
well as describe previously well-known and more recently
published epidemiologic, clinical, histologic, cytological,
and radiologic features of ETANTR. Our case is the only
the second autopsy report of ETANTR according to our
review of the literature (after Kleinschmidt-DeMasters et
al.), and since the integrity of the tumor was never disrupted
neurosurgically, we may observe the end-stage natural his-
tory of this tumor. This tumor has a poor prognosis, and due
to the paucity of cases reported so far, its true biological
behavior is far from being definitely recognized. We hope
that our case will increase awareness of ETANTR and could
bring a contribution to the knowledge on this tumor.
Case report
A 17-month-old boy was admitted to the Department of
Neurosurgery, Children’s University Hospital in Cracow due
to aggravating problems with balance. Starting a week earlier,
the parents noticed that the boy had a tendency to tilt the head
to the right and would choke when drinking. Neurologic
examination found the following deficits: cerebellar distur-
bances of balance illustrated by the boy’s staggering and
inability to walk, compulsory tilting of the head to the right,
slight right pyramidal hemiparesis, left VI and VII cranial
nerve palsies, bulbar signs demonstrated by choking, weak
pharyngeal and palatal reflexes, and a suspected lesion in the
visual field which could not be confirmed due to the child’s
lack of cooperation. Computer tomography (CT) and magnet-
ic resonance imaging (MRI) revealed an enormous tumor
(44×35×45 mm in CT and 35×36×32 mm in MRI) in the
brainstem, mostly in the left pons and medulla oblongata
(Fig. 1a, b). The tumor was hyperintense in T2 and showed
heterogenous contrast enhancement in T1 with narrowing of
the fourth ventricle (Fig. 1b). There were no features of supra-
tentorial hydrocephalus in spite of evidence of elevated pres-
sure in the posterior fossa. The state of the child was unstable
and the risk of its marked worsening due to operation was
high. Even the biopsy bore a significant risk. As a result, the
parents, after meticulous consideration of the pros and cons,
did not give consent to neither an operation nor biopsy on
assumption that the child would receive chemotherapy, which
was immediately introduced. Consecutively, the child was
transferred to the Department of Pediatric Hematology and
Oncology, Children’s University Hospital in Cracow. Further
diagnostics did not reveal any other foci of disease. Based on
the clinical picture and neuroimaging, a malignant glioma of
the brainstem was tentatively diagnosed and chemotherapy
was introduced accordingly with two cycles of cisplatin, eto-
poside, and vincristine, and one cycle of cyclophosphamide,
etoposide, and vincristine. Two months after first admission,
the child showed signs of ataxia and decreased muscle tone.
Soon, the child’s condition abruptly worsened with severe
vomiting and a forced retroflexed position. Repeated MRI
revealed enlargement of the tumor (52×50×54 mm) and
supratentorial hydrocephalus due to compression of the cere-
bral aqueduct with transudation (Fig. 1c). The hydrocephalus
was treated with implantation of a ventriculo-peritoneal shunt,
and chemotherapy with irinotecan and carboplatin was intro-
duced. The hydrocephalus remitted but the child relentlessly
deteriorated as the tumor continued to enlarge and died
3 months after hospitalization.
An autopsy of the brain performed at Department of
Pathology, Children’s University Hospital, revealed an enor-
mous tumor inside left cerebellar hemisphere partially oc-
cupying the pons and also expanding to the midbrain. The
tumor distorted the whole brainstem and cerebellum, push-
ing aside and compressing the fourth ventricle, but definite-
ly not originating from it (Fig. 1d). This confirmed the
previous MRI findings of a primary brainstem tumor
(Fig. 1a). On cross section, the tumor showed uniform
consistency, slightly lower than the normal brain tissue.
The tumor had well marked borders with a smooth transition
into adjacent apparently normal tissue.
Microscopic pictures represented a very conspicuous pat-
tern with relatively paucicellular neuropil-like background
with numerous and rather evenly distributed cellular densi-
ties populated with small undifferentiated cells (Fig. 1e).
Rosettes formed another characteristic element of the tumor
(Fig. 1f). Neuropil zones, in contrast to the cellular zones,
showed immunopositivity to synaptophysin (Fig. 2a). Both
in cellular zones and neuropil zones, there were scattered
characteristic rosettes, totally negative to synaptophysin
(Fig. 2b) but strongly positive to vimentin (Fig. 2c). The
rosettes had an “empty,” homogenous core, but frequently
with a delicate eosinophilic contouring reminiscent of epen-
dymoblastic rosettes, though somewhat more delicate than
those occurring in typical ependymoblastoma (Fig. 1e, f).
The rosettes were also weakly positive for glial fibrillary
acidic protein (GFAP) and for S100 protein (Fig. 2d).
However, in neuropil zones, there were cells present with
the immuno- and morphophenotype of astrocytes (GFAP+
and some S100+). Moreover, outside of the rosettes,
synaptophysin-positive mature neuron-like cells were noted
(Fig. 2b), and some were even strongly positive for synap-
tophysin, in spite of resembling astrocytes (Fig. 2e). Ki-67
expression was high but limited to rosettes (Fig. 2f) and
cellular zones especially around the vessels. No areas of
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frank necrosis or any “pathological” forms of endothelial
proliferation were noted. However delicate vessels were
numerous, frequently surrounded by undifferentiated cells
that do not conform to the description of “perivascular
formations” or pseudorosettes.
Discussion
The neuropathological findings in the presented case of
ETANTR, especially the very distinct border between tumor
and apparently normal tissue, could be observed in the
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Fig. 1 a MRI, 3DFSPGRT1 sequence, sagittal plane. The tumor is
localized in the brainstem and is extremely expanding and deforming
its structure. Noteworthy is severe compression of the fourth ventricle,
but evidently between the tumor and lumen of the fourth ventricle,
there remains a thin, uninterrupted strip of brain tissue (arrow). bMRI,
DGRET1 with contrast, axial plane. Contrast enhancement within the
tumor is conspicuously insignificant. c MRI, frFSET2, coronal plane.
The tumor appears as a very well delineated expansive process, with
heterogeneous signal, containing some fluid-filled areas at the level of
fourth ventricle and medial part of left cerebellar hemisphere, which
has atrophied. The tumor molds and compresses the brainstem and
obliterates the fourth ventricle. Supratentorially, there are features of
hydrocephalus with transudate of CSF into surrounding brain tissue. d
Macroscopic cross section of the tumor at the level of the cerebellum.
Noteworthy is the very distinct border between the tumor and appar-
ently untouched but evidently severely displaced and compressed
cerebellar tissue. e Characteristic mixture of neuropil-like paucicellular
zones with quite uniformly scattered cellular “densities” consisting of
small undifferentiated cells. Both within densities and also directly
within neuropil zones, one could discern rosettes which are quite
characteristic for this tumor, H&E, objective magnification ×10. f A
close-up view of rosettes. Some with empty core but delicately con-
toured with pinkish line, and some with homogenous featureless core
(arrow), H&E, objective magnification ×40
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whole cross section of the brain during autopsy examina-
tion. This suggests that this tumor rather expands within the
cerebral/cerebellar tissue rather than invades it. If so, most if
not all cellular elements within tumor are of neoplastic
origin (probably including a de novo formed vascular
bed). One may speculate that cellular “densities” and in
particular rosettes supposedly recapitulating primitive neu-
ral tube represent germinative centers, and in turn, the
neuropil paucicellular zones are essentially the result of
maturation. The maturation is evidently multidirectional as
for the cell lineages since within the tumor one can find
ganglion cells as well as glia, and probably also “hybrid”
cells like the ones that show strong synaptophysin immuno-
reactivity and astrocytic-like morphology (Fig. 2b). As a
result, ETANTR can justifiably be recognized as an embry-
onal tumor with a characteristic multifocal germinative pro-
cess. In spite of the remarkable size of tumor, there was no
evidence of a spread, neither hematogenous nor via CSF.
ETANTR has exhibited metastases within the neuroaxis in
only a minority of cases [7].
ETANTR was first described by Eberhart et al. in 2000 as a
variant of pediatric embryonal brain tumors [5]. ETANTR
occurs in children aged 4 and under, mostly in children under
2, and is more common in girls, unlike the other CNS embry-
onal tumors, which occur mostly or equally in boys [7]. Most
are located in the supratentorial region, occasionally infratento-
rially, and rarely in the spinal cord [7]. In addition to our case
report, clinical symptoms and features of ETANTR include
increased intracranial pressure, seizures, hemiparesis, cerebellar
signs, cranial nerve palsies, and other neurologic deficits [14].
Microscopically, ETANTR is characterized by undifferen-
tiated neuroepithelial cells resembling those of classic PNET,
abundant well-differentiated neuropil, and ependymoblastic
rosettes scattered throughout paucicellular regions of neoplas-
tic neuropil [7]. Homer Wright, Flexner–Wintersteiner, and
pseudovascular rosettes may also appear. Unlike AT/RT,
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Fig. 2 a The more cellular
zones (asterisk), in contrary to
neuropil background, are rather
negative for synaptophysin,
objective magnification ×20. b
All rosettes were negative for
synaptophysin. Apart from the
rosettes, strongly
synaptophysin-positive cells
with prominent processes
resembling astrocytes rather
than neurons were noted,
objective magnification x40. c
Both rosettes and almost all
cells within cellular “densities”
are strongly immunopositive
for vimentin, objective
magnification ×40. d Rosettes
are negative for S100.
However, between the rosettes
there are S-100 positive cells
with marked processes,
objective magnification ×20. e
Some mature looking
synaptophysin-positive neurons
(arrowheads) are scattered
within neuropil, objective
magnification ×40. f
Proliferating activity as
evidenced by immunopositivity
to Ki67 was marked within
rosettes and also around vessels
(not shown in this picture),
objective magnification ×40
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ETANTR has no rhabdoid cells, and unlike medulloepithe-
lioma, there are no epithelial-like formations [14]. ETANTR
has distinct ependymoblastic rosettes in both hypercellular
and acellular regions. The hypercellular regions have small
blue hyperchromic cells with a round nuclei and indistinct cell
borders [7]. Al-Hussain described rhabdomyoblastic and mel-
anocytic differentiation in a single case of ETANTR which
had not been reported before [1].
Numerous cytogenetic studies have been performed on
ETANTR in an effort to uniquely identify this tumor. These
include polysomy of chromosome 2 [3, 7, 16] and abnormal-
ities in chromosome 17 including isochromosome 17q and
polysomy 17 [6]. Such abnormalities of chromosome 17 are
also found in medulloblastoma [13], while polysomy of chro-
mosome 2 appears to be a unique differentiating feature of
ETANTR [2]. Amplification of 19q13.42 with upregulation of
microRNA clusters and protein-coding genes has also been
noted as a unique feature [16]. Korshunov et al. identified
19q13.42 amplification in 95 % of ETANTR and 90 % of
ependymoblastomas [10], and more recently, Nobusawa et al.
identified 19q13.42 amplification in three out of four
ETANTR, one medulloepithelioma with ETANTR compo-
nents, and one ependymoblastoma [15].
In MRI, ETANTR presents as a well-demarcated solid
mass with surrounding edema often producing marked mass
effects. Most tumors are solid ranging from 2 to 8 cm in
diameter, while few may show a cystic component and
microcalcifications [7, 14]. The tumor appears hypointense
on T1 and hyperintense on T2 with varying enhancement as
cases of homogenously, heterogeneously, and non-
enhancing lesions have been reported [7, 14]. MR spectros-
copy reveals a choline peak and a high ratio of choline/as-
partate suggesting hypercellularity of the tumor [7]. The
tumor grossly appears as a pinkish white neoplasm infiltrat-
ing the surrounding brain parenchyma with occasional well-
demarcated borders. Five cases with dural attachment have
been reported [7, 14]. Spread occurs through the cerebro-
spinal fluid often with leptomeningeal metastases [9, 14].
Most tumors were resectable upon first presentation al-
though recurrences were common. Current treatment strate-
gy revolves around complete tumor resection, systemic
chemotherapy, and craniospinal radiation when appropriate.
Overall, few children remain free of disease such as the 4 of
29 cases reviewed by Gessi [7]. Most recent studies show
that 76 % of patients have died with a median survival of
9 months [7]. Hope for tumor-free survival is evident though
as a case presented by Manjila remains alive with no signs
of recurrences 7 years after surgery [13].
ETANTR shares numerous features of ependymoblas-
toma and even some authors have suggested removing the
diagnosis of ependymoblastoma from the WHO classifica-
tion of CNS tumors due to its lack of specificity and claims
of obsolescence. Judkins found eight instances of
ependymoblastoma that upon further review with proper
sampling were rediagnosed as ETANTR [8]. Korshunov
revealed high cytogenetic homology between ETANTR
and ependymoblastoma [10].
As mentioned, the number of reported cases of
ETANTR is low. Approximately 50 cases and less than
20 papers of ETANTR have been published. The largest
single study of ETANTR was published by Gessi who
reviewed 29 cases with seven original cases [7]. Cases
reviewed by Gessi and additional cases were reported by
Niguez [14], Manjila [13], Buccoliero [3], Pfister [16],
Al-Hussain and Dababo [1], Dunham [4], Fuller [6], La
Spina [11], and other authors. Only one autopsy case
apart from our own has been published [9]. Prognosis
of ETANTR is poor which is exemplified by the 21
deaths of 29 cases reported by Gessi [7], death of both
cases reported by Niguez [14], death of one of two cases
reported by Manjila [13], and the fatal case presented
here.
Conclusion
Our case together with other cases of ETANTR reveals that
ETANTR has a unique and specific histopathologic and
cytologic profile that may be recognized as a unique entity
within CNS PNET. It is characterized by undifferentiated
neuroepithelial cells, abundant well-differentiated neuropil,
and ependymoblastic rosettes abruptly arising from pauci-
cellular regions of neoplastic neuropil. Our case of
ETANTR investigated by autopsy suggests that the tumor
may develop for a substantial time by expansion rather than
true invasion. In our opinion, ETANTR appears to be a
tumor with multifocal germinative activity and maturation
leading to its signature appearance of hypercellular rosettes
dispersed within the neuropil. Prognosis is poor with ap-
proximately 76 % of patients succumbing to disease and
only five patients have no evidence of disease. In the
12 years since its first description in 2000, approximately
50 cases and less than 20 papers on ETANTR are present in
the literature. A call for more cases of ETANTR is made by
us and many other authors in order to better characterize this
often fatal tumor’s behavior and response to both surgical
and chemotherapeutic treatment protocols.
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